Publications by authors named "M Sagara"

Aims/introduction: In patients with diabetes, obesity is an aggravating factor for glycemic control and its vascular complications. However, the psychological and behavioral characteristics of those patients with obesity have not been fully clarified. This study investigated eating and coping behavior, personality traits, quality of life (QOL), and depression status in patients with diabetes with or without obesity.

View Article and Find Full Text PDF

Myasthenia gravis (MG), primarily caused by acetylcholine receptor (AChR) autoantibodies, is a chronic autoimmune disorder causing severe muscle weakness and fatigability. In particular, seronegative MG constitutes 10%-15% of MG cases and presents diagnostic challenges especially in early-onset female patients who often show severe disease and resistance to immunosuppressive therapy. Furthermore, the immunopathology of seronegative MG remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate how neonatal respiratory support affects lung function in very low birth weight children with bronchopulmonary dysplasia (BPD) as they reach school age.
  • Researchers reviewed data from 78 BPD children who had their lung function assessed at ages 8-9, finding that 31% exhibited abnormalities in lung function, correlated with the type of respiratory support they received.
  • Key findings included that antenatal steroid use reduced the risk of lung function abnormalities, while needing positive-pressure support at 37 weeks of postmenstrual age was linked to a higher risk of abnormal lung function.
View Article and Find Full Text PDF

Objective: Cardiac autonomic neuropathy (CAN) is an independent risk factor for cardiovascular mortality and also is associated with a high risk of lethal arrhythmias and sudden death in people with type 1 or 2 diabetes. Heart rate variability (HRV) is an index of cardiac autonomic function. To investigate the relationship between HRV and arterial stiffness evaluated by the cardio-ankle vascular index (CAVI), a relatively new marker for arterial stiffness and a predictor of cardiovascular disease, in patients with type 2 diabetes.

View Article and Find Full Text PDF